15
Participants
Start Date
January 31, 2017
Primary Completion Date
July 31, 2018
Study Completion Date
October 31, 2020
Aspirin
81mg aspirin taken once per day in the morning
Placebo
placebo taken once per day in the morning
Withdrawal from alpha1 antitrypsin replacement therapy
After the completion of the randomization to aspirin and placebo, participants who are on alpha1 replacement therapy are asked to withhold their usual alpha1 antitrypsin replacement therapy for 5 weeks. This is not randomized.
Columbia University, New York
Collaborators (1)
Alpha-1 Foundation
OTHER
Stony Wold-Herbert Fund, Inc.
OTHER
Columbia University
OTHER